Liuwei Dihuang Pills in the Treatment of Senile Dementia: A Review

Open Access

Issue		BIO Web Conf. Volume 59, 2023 2023 5^th International Conference on Biotechnology and Biomedicine (ICBB 2023)


Article Number		02022
Number of page(s)		6
Section		Precision Medicine and Drug Development and Preparation
DOI		https://doi.org/10.1051/bioconf/20235902022
Published online		08 May 2023

Jia L., Quan M., Fu Y., et al. Dementia in China: epidemiology, clinical management, and research advances[J]. Lancet Neurol. 2020, 19(1): 81–92. [CrossRef] [Google Scholar]
Melnikova I. Therapies for Alzheimer's disease[J]. Nat Rev Drug Discov. 2007, 6(5): 341–342. [CrossRef] [PubMed] [Google Scholar]
Tanzi R E. FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease[J]. ACS Chem Neurosci. 2021, 12(15): 2714–2715. [CrossRef] [Google Scholar]
Chen J., Wu L., Wu Y., Luo Yl, Huang Xiaodan, and Chen Wei. Research progress of treating vascular dementia from Five viscera. Hunan Journal of Traditional Chinese Medicine. 2020, 36(01), 143–145. [Google Scholar]
Fang L., Fan Y. P., and Wang L. Clinical application of Liuwei Dihuang Wan (decoction). Chinese Journal of Traditional Chinese Medicine. 2013, 28(07), 2181–2185. [Google Scholar]
Shen Y. P. Comparison of improvement effects of Liuwei Dihuang Pill and Olanzapine on mental and behavioral symptoms of Alzheimer's disease. Review of Traditional Chinese Medicine. 2013, 19(12), 39–41. [Google Scholar]
Duan F. R., and Lu X. L. Comparison between Liuwei Dihuang Wan and Olanzapine in improving mental and behavioral symptoms of Alzheimer's disease. Prescription drugs in China 2014, 12(10): 58–59. [Google Scholar]
Du G. L., Li H., Liu D., and Hou Y. P.. Application and effect of Liuwei Dihuang Pills in the adjuvant therapy of Alzheimer's disease. Hebei Pharmaceutical 2015, 37(11): 1661–1663. [Google Scholar]
Fu Y. J.. A comparative study on the improvement effects of Liuwei Dihuang Pill and Olanzapine on mental and behavioral symptoms of Alzheimer's disease. Chinese Journal of Modern Medicine. 2015, 17(07), 55–56. [Google Scholar]
Chen J., Jiang J. L., Yuan M. Y., and Zheng L. Clinical observation of Liwei Dihuang Wan combined with Donepezil hydrochloride in treatment of kidney-yin deficiency type Alzheimer's disease. Journal of Clinical Rational Drug Use. 2017,10(01), 64–65. [Google Scholar]
Zhang L., Li F. L., and Ma L. Clinical observation of Liuwei Dihuang Pill combined with Western medicine in the treatment of mild and moderate Alzheimer's disease. World Traditional Chinese Medicine. 2017, 12(11), 2659-2661-2665. [Google Scholar]
Gu J. K., Luo H. L., and Zhang Z. To investigate the effect of Liuwei Dihuang Pill and Olanzapine on improving mental symptoms in senile dementia patients. Clinical Research of Traditional Chinese Medicine. 2018, 10(14), 66-67-69. [Google Scholar]
Jin H. Q.. Clinical effect of Liwei Dihuang Pill combined with Donepezil hydrochloride on senile dementia with kidney-yin deficiency. Electronic Journal of Clinical Medicine Literature 2020, 7(03): 25–59. [Google Scholar]
Song W. T. Effects of Liuwei Dihuang Pills combined with Memantine on cognitive function and QOL-AD score in Alzheimer's disease. Inner Mongolia Journal of Medicine. 2021, 53(09): 1103–1105. [Google Scholar]
Zhou C. H., Xiong Y. T., and Yi L. L.. Effects of Mingmingning Capsule on neurotransmitters in aged mice. Evaluation and analysis of hospital drug use in China. 2016, 16(06): 731–733. [Google Scholar]
Zhu Z. K., Zhang L., Liu C., Wang X., Liu H. H., and Zhao D. Y. Intervention of tonifying kidney and replenishing essence on hippocampal autophagy in mice with kidney deficiency in Alzheimer's disease. Chinese Journal of Experimental Formulae. 2019, 25(20): 43–48. [Google Scholar]
Song J. Y., Ding R., Li J. L., CAI J., Yuan Y., Jia Y. Q., and Zhang Z. Q.. Effect of Liuwei Dihuang Pills on autophagy and memory function of SAMP8 mice through PI3K/Akt/FoxO3a pathway. Chinese Journal of Experimental Formulae. 2022, 28(17): 1–8. [Google Scholar]
Zhu Z. K., Liu Y. Q., Wang B., Zhang L., Wang Y. J., Wang Z., Liu C., and Zhao D. Y. Effect of Liuwei Dihuang Pills on autophagy of Aβ-induced SH-SY5Y cells and its mechanism. World Science and Technology -Modernization of Traditional Chinese Medicine. 2022, 24(02): 670–677. [Google Scholar]
Bourasset F., Ouellet M., Tremblay C., et al. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease[J]. Neuropharmacology. 2009, 56(4): 808–813. [CrossRef] [Google Scholar]
Bu Q. Y., Gao T K., Li F., Gao Y., and Xue W. G.. Overview of studies on the clearance of the menstrual blood-brain barrier of beta-amyloid protein in the brain in Alzheimer's disease. Chinese Journal of Cerebrovascular Diseases. 2014, 11(12): 663–668. [Google Scholar]
Jia Y. Q., Song Y. J., Yuan Y., Li J. L., Ding R., and Zhang Z. Q.. Effect of Liuwei Dihuang Pills on cerebral microvascular regulation of SAMP8 mice mediated by RAGE/LRP1 receptor. Chinese Journal of Experimental Formulae. 2022, 28(16): 9–18. [Google Scholar]
Zhao C., Jiang Z., Tian L., et al. Bioinformatics-Based Approach for Exploring the Immune Cell Infiltration Patterns in Alzheimer's Disease and Determining the Intervention Mechanism of Liuwei Dihuang Pill[J]. Dose Response. 2022, 20(3): 1495865515. [Google Scholar]
Zhang Y. H., Zhou X. Q., Wu D. H., Yang M. L., Zheng C. X., and Tong T. H.. Study on the mechanism of Liuwei Dihuang Pills in the treatment of Alzheimer's disease based on network pharmacology. Chinese Modern Applied Pharmacy. 2022, 39(02): 154–160. [Google Scholar]
Zeng P., and Zhou H.. Consideration on the homogeneity of key ingredient screening of "different diseases and different prescriptions" in network pharmacology. Chinese Journal of Experimental Formulae. 2022, 28(18): 177–191. [Google Scholar]
Wang D., Zhang N., Chen X., Xue A., Ding L. X., and Lei X. To explore the potential mechanism of Liuwei Dihuang Pills in the treatment of AD based on UPLC-LTQ-Orbitrap-MS and network pharmacology. Journal of Pharmaceutical Analysis. 2022, 42(04): 580–589. [Google Scholar]
Zhao X. F., Kong H. W., Wang J. S., and Xu G. W. Identification of chemical and metabolic components in Liuwei Dihuang Pills by UFLC-ESI-IT-TOF. World Science and Technology (Modernization of Chinese Medicine). 2009, 11(01): 153–157. [Google Scholar]
Zhao H. Study on serum pharmacochemistry of Liuwei Dihuang Wan. Journal of Medical Forum. 2010, 31(19): 70–71. [Google Scholar]
Bai Y. Y., Chen Q., Liang L. N., Li X. L., Liang J., and Ma Q. Y.. Effect of dispelling wind and opening passages on intraocular distribution of effective components in Liuwei Dihuang Pills. Chinese Journal of Traditional Chinese Ophthalmology. 2017, 27(03): 141–145. [Google Scholar]
Leng W. Effects of ragin, paeoniflorin and paeonol in Liuwei Dihuang Pills on cAMP in rat preadipocytes induced by adrenalin. Journal of Hunan University of Traditional Chinese Medicine. 2010, 30(09): 74–77. [Google Scholar]
Li Q. J., Wang P., Wang M. J., Kang S. Y., Zhang Y., Zhang A. H., and Wang X. J.. Study on the intervention of Liuwei Dihuang Wan on Cerebral palsy rat model based on TCM prescription metabonomics technique. World Science and Technology --Modernization of Traditional Chinese Medicine. 2016, 18(10): 1684–1696. [Google Scholar]
Liu J., Zhou Y., Zhang G. X., Tan Y. H., Xiao J. Y., Wu Y. Y., Zeng L., and Du B. Y.. The gap junction mechanism of Liuwei Dihuang Pills to increase the effect of suicide gene on hepatocellular carcinoma cells. Journal of Guangzhou University of Traditional Chinese Medicine. 2014, 31(01): 103–108. [Google Scholar]
Du B. Y., Zhou Y., Yi H., Zhang G. X., Tan Y. H., Wu Y. Y., Guo Y. R., and Luo H.. The synergistic effect of Liuwei Dihuang Pills on killing hepatocellular carcinoma cells by suicide gene. Chinese Journal of Experimental Formulae. 2013, 19(16): 220–224. [Google Scholar]
Dai B., Li X. F., Xiao Z. Z., Shen K. J., Zhao J., and Peng L. Effect of the combination of four components of Liuwei Dihuang Pills on the proliferation and differentiation of rat proadipocytes in optimal concentration compatibility. Chinese Medicinal Materials. 2010, 33(12): 1904–1908. [Google Scholar]
Dai B., Xiao Z. Z., Liu L., Leng W., Mei J., and Zou S. H.. Effect of monoside of Liuwei Dihuang Pills on proliferation and differentiation of rat preadipocytes. Chinese Journal of Clinical Pharmacology and Therapeutics. 2007(11): 1245–1249. [Google Scholar]
Zhang G. X., Wang S. P., ZL, Tan Y. H., Wu Y. Y., and Du B. Y.. Synergistic effect of Liuwei Dihuang Wan on killing B16 cells by suicide gene. New Chinese Medicine and Clinical Pharmacology. 2014, 25(02): 153–158. [Google Scholar]
Lipinski C. A., Lombardo F., Dominy B. W., et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings[J]. Adv Drug Deliv Rev. 2001, 46(1-3): 3–26. [CrossRef] [Google Scholar]
Xiong G., Wu Z., Yi J., et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties[J]. Nucleic Acids Res. 2021, 49(W1): W5–W14. [CrossRef] [PubMed] [Google Scholar]
Yu L. Preliminary study on multiple protective effects of cornus officinalis on Alzheimer's disease and related mechanisms. Peking Union Medical College. 2020. p 128. [Google Scholar]
Banerjee P., Eckert A. O., Schrey A. K., et al. ProTox-II: a webserver for the prediction of toxicity of chemicals[J]. Nucleic Acids Res. 2018, 46(W1): W257–W263. [CrossRef] [PubMed] [Google Scholar]
Wei Z., Gao Y., Meng F., et al. iDMer: an integrative and mechanism-driven response system for identifying compound interventions for sudden virus outbreak[J]. Brief Bioinform. 2021, 22(2): 976–987. [CrossRef] [PubMed] [Google Scholar]
Zeng P., Ye Chao-yuan, Su Hong-Fei, and Tian Qing. Research progress of Bushen Yizhi prescription in the treatment of Alzheimer's disease. Chinese Journal of Experimental Formulary. 2022: 1–12. [Google Scholar]
Jiang Z. Y., Zhang X. M., Zhang F. X., et al. A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis[J]. Planta Med. 2006, 72(10): 951–954. [CrossRef] [PubMed] [Google Scholar]
Hinz F. I., Geschwind D. H.. Molecular Genetics of Neurodegenerative Dementias[J]. Cold Spring Harb Perspect Biol. 2017, 9(4). [Google Scholar]
Islam B. U., Tabrez S.. Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets[J]. Int J Biol Macromol. 2017, 97: 700–709. [CrossRef] [Google Scholar]
Zeng P., Su H. F., Ye C. Y., et al. Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer's Disease From the Perspective of Pathophysiological Processes[J]. Front Pharmacol. 2021, 12: 806984. [CrossRef] [Google Scholar]
Xu M., Zhang D. F., Luo R., et al. A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease[J]. Alzheimers Dement. 2018, 14(2): 215–229. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.